Literature DB >> 8701978

Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia.

K Polyak1, S R Hamilton, B Vogelstein, K W Kinzler.   

Abstract

Aberrant crypt foci with dysplasia are thought to be the first detectable lesions of colorectal neoplasia. Because cell cycle disruption appears crucial for tumorigenesis, we analyzed the immunohistochemical expression patterns of the prototype cyclin-dependent kinase inhibitor p21 WAF1/CIP1 and the proliferation marker Ki67 in the early stages of colorectal tumorigenesis. In colorectal epithelium, p21 WAF1/CIP1 expression was undetectable in the lower third of the crypts, where Ki67 was expressed, but then sharply increased as cells passed out of the proliferating zone and migrated toward the humen. Hyperplastic polyps retained this normal compartmentalized pattern. In contrast, markedly decreased p21 WAF1/CIP1 immunostaining was observed in dysplastic aberrant crypt foci as well as in small adenomas. Moreover, the compartmentalization of Ki67 and p21 WAF1/CIP1 was lost, as Ki67 expression extended into the small p21-expressing zone at the top of the crypts. These data suggest that the dysregulated expression of cell-cycle-controlling genes and the consequent release from normal cell cycle controls may represent an essential early step in colorectal neoplasia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8701978      PMCID: PMC1865297     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

Review 2.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

3.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

4.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

5.  Enzyme-altered foci in colons of carcinogen-treated rats.

Authors:  B J Barrow; M A O'Riordan; T A Stellato; B M Calkins; T P Pretlow
Journal:  Cancer Res       Date:  1990-03-15       Impact factor: 12.701

6.  Pathogenesis of polyps (adenomas).

Authors:  S R Hamilton
Journal:  Dis Colon Rectum       Date:  1983-06       Impact factor: 4.585

7.  Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings.

Authors:  R P Bird
Journal:  Cancer Lett       Date:  1987-10-30       Impact factor: 8.679

8.  Aberrant crypts: potential preneoplastic lesions in the murine colon.

Authors:  E A McLellan; R P Bird
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

9.  Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues.

Authors:  F S Leach; K Polyak; M Burrell; K A Johnson; D Hill; M G Dunlop; A H Wyllie; P Peltomaki; A de la Chapelle; S R Hamilton; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1996-01-15       Impact factor: 12.701

10.  Aberrant crypts: putative preneoplastic foci in human colonic mucosa.

Authors:  T P Pretlow; B J Barrow; W S Ashton; M A O'Riordan; T G Pretlow; J A Jurcisek; T A Stellato
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

View more
  30 in total

1.  Top down or bottom up? Competing management structures in the morphogenesis of colorectal neoplasms.

Authors:  N A Wright; R Poulsom
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

2.  Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.

Authors:  H Hayashi; H Miyamoto; T Ito; Y Kameda; N Nakamura; Y Kubota; H Kitamura
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 3.  Calcium, a Cell Cycle Commander, Drives Colon Cancer Cell Diffpoptosis.

Authors:  Ahmed A Abd-Rabou
Journal:  Indian J Clin Biochem       Date:  2016-03-30

4.  Loss of nuclear p21(Cip1/WAF1) during neoplastic progression to metastasis in gamma-irradiated p21 hemizygous mice.

Authors:  Robert W Engelman; Rosalind J Jackson; Domenico Coppola; Walker Wharton; Alan B Cantor; W Jack Pledger
Journal:  Exp Mol Pathol       Date:  2007-01-04       Impact factor: 3.362

5.  AP4 encodes a c-MYC-inducible repressor of p21.

Authors:  Peter Jung; Antje Menssen; Doris Mayr; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

6.  Metaplastic (hyperplastic) polyps of the large bowel: benign neoplasms after all?

Authors:  G T Williams
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 7.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

8.  Upregulation of p21Waf1/Cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet.

Authors:  Kristy Covert Crim; Lisa M Sanders; Mee Young Hong; Stella S Taddeo; Nancy D Turner; Robert S Chapkin; Joanne R Lupton
Journal:  Carcinogenesis       Date:  2008-06-20       Impact factor: 4.944

Review 9.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

10.  Sulforaphane Increases Cyclin-Dependent Kinase Inhibitor, p21 Protein in Human Oral Carcinoma Cells and Nude Mouse Animal Model to Induce G(2)/M Cell Cycle Arrest.

Authors:  Jun-Hee Kim; Ki Han Kwon; Ji-Youn Jung; Hye-Suk Han; Jung Hyun Shim; Sejun Oh; Kyeong-Hee Choi; Eun-Sun Choi; Ji-Ae Shin; Dae-Ho Leem; Yunjo Soh; Nam-Pyo Cho; Sung-Dae Cho
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.